Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:07 AM
Study NCT ID:
NCT02701634
Status:
TERMINATED
Last Update Posted:
2018-12-26
First Post:
2016-02-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD)
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-27
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-06
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-24
First Submit QC Date:
None
Study First Post Date:
2016-03-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-05
Results First Submit QC Date:
None
Results First Post Date:
2018-12-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-05
Last Update Post Date:
2018-12-26
Last Update Post Date Type:
ACTUAL